tiprankstipranks
Hawkins Inc (HWKN)
NASDAQ:HWKN
Want to see HWKN full AI Analyst Report?

Hawkins (HWKN) AI Stock Analysis

167 Followers

Top Page

HWKN

Hawkins

(NASDAQ:HWKN)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
$138.00
▼(-0.74% Downside)
Action:Reiterated
Date:08/04/26
The score is driven primarily by solid financial performance (profitability, scale gains, and positive cash generation), but is held back by notably weak technical momentum (below major moving averages with negative MACD) and a relatively expensive valuation (P/E ~32.9 with a low ~0.59% yield). Governance-related corporate events provide a modest positive offset.
Positive Factors
Revenue scaling & diversification
Multi-year revenue growth from ~$775M to ~$1.11B TTM shows durable demand and successful scaling across Hawkins’ Industrial, Water Treatment and Health & Nutrition lines. Sustained scale improves supplier access, negotiating leverage, and supports long-term service and distribution economics.
Negative Factors
Rising leverage
A step-up in debt to ~$258M (debt/equity ~0.49) from lower prior-year levels increases financial leverage and interest exposure. Higher indebtedness can constrain flexibility for M&A or capex, and elevates risk if margins or demand soften in cyclical end markets.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue scaling & diversification
Multi-year revenue growth from ~$775M to ~$1.11B TTM shows durable demand and successful scaling across Hawkins’ Industrial, Water Treatment and Health & Nutrition lines. Sustained scale improves supplier access, negotiating leverage, and supports long-term service and distribution economics.
Read all positive factors

Hawkins Key Performance Indicators (KPIs)

Any
Any
Operating Income by Segment
Operating Income by Segment
Shows profit after operating costs for each segment, identifying which businesses generate the most operating earnings and which absorb corporate overhead. Rising operating income in key segments points to improving profitability or scale, while weak or declining results can indicate margin pressure or inefficient operations.
Chart InsightsHawkins executed a clear mid‑2024 reporting reclassification: legacy Industrial and Health & Nutrition operating income were moved into the newly reported Food & Health Sciences and Industrial Solutions lines. Water Treatment has become the dominant, but highly project‑driven, profit engine with large mid‑year spikes (growing peak levels into 2025), while Food & Health Sciences showed an initial post‑reorg lift that tapered through 2025 and Industrial Solutions is a smaller, steadier contributor. Investors should focus on Water Treatment’s project pipeline and timing—seasonality makes near‑term comparability and margin sustainability the primary risks.
Data provided by:The Fly

Hawkins (HWKN) vs. SPDR S&P 500 ETF (SPY)

Hawkins Business Overview & Revenue Model

Company Description
Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industria...
How the Company Makes Money
Hawkins makes money primarily by selling chemicals and ingredients and by providing related services, with revenue generally recognized from product shipments and service delivery. Its key revenue streams include: (1) Industrial: sales of bulk and...

Hawkins Financial Statement Overview

Summary
Fundamentals are solid: healthy profitability (TTM gross margin ~22.6%, net margin ~7.5%), meaningful revenue scale-up (~$775M in 2022 to ~$1.11B TTM), and positive cash generation (TTM OCF ~$148M; FCF ~$92M). Offsetting factors include higher leverage (debt rising to ~$258M TTM; debt-to-equity ~0.49), less consistent margin/ROE expansion (ROE ~15.3% TTM, down from 2024–2025), and weaker recent free-cash-flow conversion (~60% of net income). KPI insights also flag segment reclassification around mid-2024 that reduces historical comparability and increases diligence needs around the Water Treatment concentration and seasonality.
Income Statement
78
Positive
Balance Sheet
73
Positive
Cash Flow
70
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue1.11B1.08B974.43M919.16M935.10M774.54M
Gross Profit246.70M223.75M212.74M193.64M165.12M146.52M
EBITDA174.87M175.39M159.76M137.23M117.23M95.51M
Net Income80.63M81.55M84.34M75.36M60.04M51.54M
Balance Sheet
Total Assets1.01B1.00B769.87M673.16M602.36M567.33M
Cash, Cash Equivalents and Short-Term Investments7.98M3.91M5.10M7.15M7.57M3.50M
Total Debt257.70M261.46M162.64M108.26M120.33M136.36M
Total Liabilities458.04M467.69M309.57M267.13M252.34M264.73M
Stockholders Equity548.20M534.01M460.29M406.03M350.02M302.60M
Cash Flow
Free Cash Flow91.69M86.09M70.00M119.35M29.08M14.32M
Operating Cash Flow147.99M144.33M111.10M159.50M77.40M42.84M
Investing Cash Flow-74.50M-224.10M-127.95M-122.50M-41.23M-49.76M
Financing Cash Flow-80.02M78.58M14.81M-37.41M-32.10M7.42M

Hawkins Technical Analysis

Technical Analysis Sentiment
Negative
Last Price139.03
Price Trends
50DMA
146.34
Negative
100DMA
150.96
Negative
200DMA
146.89
Negative
Market Momentum
MACD
-4.18
Positive
RSI
36.96
Neutral
STOCH
50.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HWKN, the sentiment is Negative. The current price of 139.03 is above the 20-day moving average (MA) of 137.64, below the 50-day MA of 146.34, and below the 200-day MA of 146.89, indicating a bearish trend. The MACD of -4.18 indicates Positive momentum. The RSI at 36.96 is Neutral, neither overbought nor oversold. The STOCH value of 50.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HWKN.

Hawkins Risk Analysis

Hawkins disclosed 22 risk factors in its most recent earnings report. Hawkins reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Hawkins Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$4.54B16.4212.07%2.02%-8.52%-31.91%
69
Neutral
$3.33B21.127.16%2.91%1.33%57.45%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
$2.97B16.229.16%1.71%-0.57%81.10%
59
Neutral
$2.67B32.9115.30%0.55%9.32%-4.81%
51
Neutral
$4.99B-13.91-30.38%24.25%-515.23%
46
Neutral
$2.11B-15.05-7.67%3.45%0.60%-920.33%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HWKN
Hawkins
129.91
-46.69
-26.44%
CBT
Cabot
87.62
13.62
18.41%
FUL
H.B. Fuller Company
61.07
5.72
10.34%
OLN
Olin
18.59
0.47
2.61%
AVNT
Avient
45.69
13.89
43.67%
PRM
Perimeter Solutions
35.26
17.45
97.98%

Hawkins Corporate Events

Executive/Board ChangesShareholder Meetings
Hawkins Shareholders Reaffirm Board, Auditor and Compensation
Positive
Aug 3, 2026
At Hawkins’ annual meeting of shareholders held on July 29, 2026, investors elected all eight director nominees to the board, signaling continued support for the company’s existing leadership and governance framework. Shareholders also...
Business Operations and StrategyExecutive/Board Changes
Hawkins Reclassifies Stauber Vice President in Governance Shift
Neutral
May 19, 2026
On May 13, 2026, Hawkins, Inc. reclassified Shirley A. Rozeboom, Vice President – Stauber, so that she is no longer considered an executive officer, as part of a planned transition tied to the realignment of its reporting segments effective ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 04, 2026